Advertisement
Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DiPiro, J.
Right arrow Articles by Bivins, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DiPiro, J.
Right arrow Articles by Bivins, B.
American Journal of Hospital Pharmacy, Vol 38, Issue 3, 320-334
Copyright © 1981 by American Society of Health-System Pharmacists


Articles

Antimicrobial prophylaxis in surgery: Part 1

JT DiPiro, KE Record, KS Schanzenbach, and BA Bivins


The use of antimicrobial agents for prophylaxis in gastrointestinal, obstetric-gynecologic, cardiovascular-thoracic, orthopedic, and head-and-neck surgery is reviewed. English-language reports of studies on antimicrobial prophylaxis in surgery are reviewed. The methodology of each study was evaluated using predetermined criteria, and "evaluable" regimens are included in this review. For each type of surgical procedure, the discussion covers normal infection rates, probable bacterial contaminants, evaluable studies, and specific treatment recommendations. Regimens found to be evaluable numbered 76, with 72 of these showing a decreased infection rate with antibiotics versus placebo. Statistically significant decreases were found in 57 regimens. When properly used, antimicrobial agents have experimental justification for use in some surgical procedures. Factors that should be considered in the risk-benefit equation include: potential for and significance of surgical infection; cost, adverse effects, and ease of administration of antimicrobial agents; development of resistant microorganisms and of superinfection; and improper reliance on antimicrobial agents with resulting disregard for aseptic technique.
 



This article has been cited by other articles:


Home page
Arch DermatolHome page
P. L. Bencini, M. Galimberti, M. Signorini, and C. Crosti
Antibiotic Prophylaxis of Wound Infections in Skin Surgery
Arch Dermatol, September 1, 1991; 127(9): 1357 - 1360.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Society of Health-System Pharmacists.
Advertisement